- Home
- MCR vs ABEO Comparison
MCR vs ABEO Comparison
Compare MCR & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCR
- ABEO
- Stock Information
- Founded
- MCR 1989
- ABEO 1974
- Country
- MCR United States
- ABEO United States
- Employees
- MCR N/A
- ABEO N/A
- Industry
- MCR Trusts Except Educational Religious and Charitable
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- MCR Finance
- ABEO Health Care
- Exchange
- MCR Nasdaq
- ABEO Nasdaq
- Market Cap
- MCR 265.5M
- ABEO 289.2M
- IPO Year
- MCR N/A
- ABEO 1980
- Fundamental
- Price
- MCR $6.42
- ABEO $5.26
- Analyst Decision
- MCR
- ABEO Strong Buy
- Analyst Count
- MCR 0
- ABEO 6
- Target Price
- MCR N/A
- ABEO $18.17
- AVG Volume (30 Days)
- MCR 66.7K
- ABEO 1.1M
- Earning Date
- MCR 01-01-0001
- ABEO 11-13-2025
- Dividend Yield
- MCR 8.52%
- ABEO N/A
- EPS Growth
- MCR N/A
- ABEO N/A
- EPS
- MCR 0.38
- ABEO 0.99
- Revenue
- MCR N/A
- ABEO $400,000.00
- Revenue This Year
- MCR N/A
- ABEO N/A
- Revenue Next Year
- MCR N/A
- ABEO $324.71
- P/E Ratio
- MCR $16.61
- ABEO $5.31
- Revenue Growth
- MCR N/A
- ABEO N/A
- 52 Week Low
- MCR $5.63
- ABEO $3.93
- 52 Week High
- MCR $6.70
- ABEO $7.54
- Technical
- Relative Strength Index (RSI)
- MCR 50.40
- ABEO 31.86
- Support Level
- MCR $6.36
- ABEO $5.19
- Resistance Level
- MCR $6.50
- ABEO $5.49
- Average True Range (ATR)
- MCR 0.07
- ABEO 0.19
- MACD
- MCR -0.01
- ABEO 0.01
- Stochastic Oscillator
- MCR 40.11
- ABEO 12.84
About MCR MFS Charter Income Trust
MFS Charter Income Trust is a United States-based closed-end fund. Its investment objective is to seek high current income, but may also consider capital appreciation. The fund invests the assets in Debt Instruments, Corporate Bonds, U.S. Government Securities, Foreign Government Securities, Securitized Instruments, Derivatives, Principal Risks, Debt Management Risk, Investment Selection Risk, Interest Rate Risk, Credit Risk, Foreign Risks, Emerging Markets Risk, Currency Risk, Leveraging Risk, Operational and Cybersecurity Risk, Active and Frequent Trading, and etc of different market countries.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.